RADIATION THERAPY ONCOLOGY GROUP
RTOG 0912
A RANDOMIZED PHASE II STUDY OF CONCURRENT INTENSITY MODULATED RADIATION THERAPY (IMRT), PACLITAXEL AND PAZOPANIB (NSC 737754)/PLACEBO, FOR THE TREATMENT OF ANAPLASTIC THYROID CANCER
RTOG 0912
A RANDOMIZED PHASE II STUDY OF CONCURRENT INTENSITY MODULATED RADIATION THERAPY (IMRT), PACLITAXEL AND PAZOPANIB (NSC 737754)/PLACEBO, FOR THE TREATMENT OF ANAPLASTIC THYROID CANCER
Protocol Participation Information
- Credentialing
- Credentialing Requirements
- Facility Questionnaire: Part I is required for this protocol.
- Dry Run Guidelines (from RTOG 0225)
- How to Participate
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- Data Submission Checklist
- ATC Compliant Treatment Planning Systems
- Structure Names
- Neck Node Atlas
- Protocol Text (http://www.rtog.org/)
Back to protocols
